Passive smoking, NAT2 polymorphism, and breast cancer risk in Israeli Arab women: a case–control study
The effect of passive smoking (PS) on breast cancer (BC) is controversial, and may be modified by polymorphism of the N-Acetyl-transferase (NAT) 2 enzyme which is involved in tobacco carcinogen metabolism. We aimed to evaluate the relationship between PS and BC by NAT2 variants in Arab–Israeli women, a unique population with low active smoking rates, and high exposure to PS.
A population-based case-control study was carried out on non-smoking 137 prevalent breast cancer patients and 274 population-based controls, aged 30–70 years. Data on past and current PS, sociodemographic, and other characteristics were retrieved through interviews, and buccal smears were provided for NAT2 analyses. Logistic regression models adjusting for potential confounders assessed the odds ratios (ORs) and 95% confidence intervals (95% CI) of the association between PS and BC.
Ever PS was associated with increased BC risk: OR = 2.22, 95% CI 1.28–3.87. Higher lifetime PS exposure was associated with higher BC risk: Compared to never exposed women, women exposed to PS most of their lives had a threefold higher BC risk (OR = 3.16, 95% CI 1.70–5.87, P trend < 0.001). NAT2 polymorphism did not modify these associations.
PS exposure in non-smoking Israeli Arab women is significantly associated with increased risk for BC, potentially allowing for specific intervention; NAT2 polymorphism does not modify this association.
KeywordsArab Breast cancer Case–control NAT2 Passive smoking
The authors of this study acknowledge and thank the Israeli Arabic women of northern Israel who participated in this study. We would also like to thank Prof Zidan of Ziv Medical Center in Zefat and Dr. Hadassah Goldberg of West Galilee Medical Center in Nahariya for their cooperation and help in conducting the study.The study was conducted as partial fulfillment of the requirements for a Ph.D. degree of Z. Regev-Avraham at the University of Haifa.
Compliance with ethical standards
Conflict of interest
The authors declare no conflicts of interest.
- 1.Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr. Accessed 21 June 2017.
- 2.Israel National Cancer Registry, Ministry of Health. Available at: http://www.health.gov.il/UnitsOffice/HD/ICDC/ICR/CancerIncidence/Pages/Breast_Invasive.aspx. Accessed 21 June 2017.
- 3.Beaber EF, Buist DS, Barlow WE, Malone KE, Reed SD, Li CI. Recent oral contraceptive use by formulation and breast cancer risk among women 20–49 years of age. Cancer. 2014;74(15):4078–89.Google Scholar
- 5.Pettersson A, Graff RE, Ursin G, Santos-Silva ID, McCormack V, Baglietto L et al. Mammographic density phenotypes and risk of breast cancer: a meta-analysis. J Natl Cancer Inst 2014;106(5).Google Scholar
- 6.Boyle P, Levin B. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans’ tobacco smoke and in voluntary smoking. 83 vol. Lyon: World Health Organization; 2008.Google Scholar
- 23.Health status in Israel 2010. Israel center for Disease Control, Israel Ministry of Health. Available at: http://www.health.gov.il/PublicationsFiles/Health_Status_in_Israel2010.pdf. Accessed 21 June 2017.
- 26.Israel Central Bureau of Statistics website http://www.cbs.gov.il/shnaton64/st02_15x.pdf. Accessed 21 June 2017.
- 32.www.ibm.com/software/analytics/spss. Accessed 24 Oct 2017.
- 39.Liu L, Wu K, Lin X, Yin Y, Zheng X, Tang X, et al. Passive smoking and other factors at different periods of life and breast cancer risk in Chinese women who have never smoked—a case–control study in Chongqing, People’s Republic of China. Asian Pac J Cancer Prev. 2000;1(2):131–7.PubMedGoogle Scholar